Development
Dyne Therapeutics, Inc.
DYN
$10.47
$0.222.15%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 123.10M | 157.82M | 207.73M | 238.21M | 256.01M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 6.28M | 10.39M | 5.44M | 11.00M | 9.58M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 129.38M | 168.22M | 213.17M | 249.21M | 265.59M |
|
|||||
Total Current Assets | 129.38M | 168.22M | 213.17M | 249.21M | 265.59M |
Net Property, Plant & Equipment | 33.39M | 34.70M | 35.93M | 37.11M | 38.41M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.32M | 2.33M | 2.32M | 2.32M | 2.32M |
Total Assets | 165.08M | 205.24M | 251.42M | 288.64M | 306.33M |
|
|||||
Total Accounts Payable | 22.94M | 3.55M | 2.72M | 8.77M | 5.26M |
Total Accrued Expenses | 23.44M | 21.43M | 12.78M | 8.17M | 18.22M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.72M | 4.71M | 4.71M | 4.64M | 4.61M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 1.00K |
Total Other Current Liabilities | -- | -- | -- | -- | 1.00K |
Total Current Liabilities | 51.10M | 29.69M | 20.22M | 21.59M | 28.09M |
|
|||||
Total Current Liabilities | 51.10M | 29.69M | 20.22M | 21.59M | 28.09M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 22.70M | 23.51M | 24.32M | 25.12M | 25.87M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 73.79M | 53.21M | 44.54M | 46.71M | 53.96M |
|
|||||
Common Stock & APIC | 723.80M | 717.92M | 712.60M | 682.90M | 649.51M |
Retained Earnings | -632.51M | -565.87M | -505.66M | -440.76M | -396.57M |
Treasury Stock & Other | -- | -13.00K | -56.00K | -203.00K | -571.00K |
Total Common Equity | 91.29M | 152.04M | 206.88M | 241.94M | 252.36M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 91.29M | 152.04M | 206.88M | 241.94M | 252.36M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 91.29M | 152.04M | 206.88M | 241.94M | 252.36M |
|